Industry: Medical Devices & Consumables
Published Date: 2024-02-05
Pages: 113 Pages
Report ld: 2419619
Request Sample
Customized Report
Sterile Serological Pipette Market Size(US$)

CAGR 2024-2030
5.2%
Market Size,2030
USD 331.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Sterile Serological Pipette market was valued at US$ 232 million in 2023 and is anticipated to reach US$ 331.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Sterile Serological Pipette, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Serological Pipette.
MARKET SEGMENTATION
REPORT SCOPE
The Sterile Serological Pipette market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sterile Serological Pipette market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Serological Pipette manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sterile Serological Pipette manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sterile Serological Pipette in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Sterile Serological Pipette Market Overview
1.1 Product Overview and Scope of Sterile Serological Pipette
1.2 Sterile Serological Pipette Segment by Type
1.2.1 Global Sterile Serological Pipette Market Value Comparison by Type (2024-2030)
1.2.2 2 ml
1.2.3 5 ml
1.2.4 10 ml
1.2.5 25 ml
1.2.6 Others
1.3 Sterile Serological Pipette Segment by Application
1.3.1 Global Sterile Serological Pipette Market Value by Application: (2024-2030)
1.3.2 Cell Culture
1.3.3 Bacteriology
1.3.4 Clinical Research
1.3.5 Others
1.4 Global Sterile Serological Pipette Market Size Estimates and Forecasts
1.4.1 Global Sterile Serological Pipette Revenue 2019-2030
1.4.2 Global Sterile Serological Pipette Sales 2019-2030
1.4.3 Global Sterile Serological Pipette Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sterile Serological Pipette Market Competition by Manufacturers
2.1 Global Sterile Serological Pipette Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sterile Serological Pipette Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sterile Serological Pipette Average Price by Manufacturers (2019-2024)
2.4 Global Sterile Serological Pipette Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sterile Serological Pipette, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sterile Serological Pipette, Product Type & Application
2.7 Sterile Serological Pipette Market Competitive Situation and Trends
2.7.1 Sterile Serological Pipette Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sterile Serological Pipette Players Market Share by Revenue
2.7.3 Global Sterile Serological Pipette Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sterile Serological Pipette Retrospective Market Scenario by Region
3.1 Global Sterile Serological Pipette Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sterile Serological Pipette Global Sterile Serological Pipette Sales by Region: 2019-2030
3.2.1 Global Sterile Serological Pipette Sales by Region: 2019-2024
3.2.2 Global Sterile Serological Pipette Sales by Region: 2025-2030
3.3 Global Sterile Serological Pipette Global Sterile Serological Pipette Revenue by Region: 2019-2030
3.3.1 Global Sterile Serological Pipette Revenue by Region: 2019-2024
3.3.2 Global Sterile Serological Pipette Revenue by Region: 2025-2030
3.4 North America Sterile Serological Pipette Market Facts & Figures by Country
3.4.1 North America Sterile Serological Pipette Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sterile Serological Pipette Sales by Country (2019-2030)
3.4.3 North America Sterile Serological Pipette Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sterile Serological Pipette Market Facts & Figures by Country
3.5.1 Europe Sterile Serological Pipette Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sterile Serological Pipette Sales by Country (2019-2030)
3.5.3 Europe Sterile Serological Pipette Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sterile Serological Pipette Market Facts & Figures by Country
3.6.1 Asia Pacific Sterile Serological Pipette Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sterile Serological Pipette Sales by Country (2019-2030)
3.6.3 Asia Pacific Sterile Serological Pipette Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sterile Serological Pipette Market Facts & Figures by Country
3.7.1 Latin America Sterile Serological Pipette Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sterile Serological Pipette Sales by Country (2019-2030)
3.7.3 Latin America Sterile Serological Pipette Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sterile Serological Pipette Market Facts & Figures by Country
3.8.1 Middle East and Africa Sterile Serological Pipette Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sterile Serological Pipette Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sterile Serological Pipette Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sterile Serological Pipette Sales by Type (2019-2030)
4.1.1 Global Sterile Serological Pipette Sales by Type (2019-2024)
4.1.2 Global Sterile Serological Pipette Sales by Type (2025-2030)
4.1.3 Global Sterile Serological Pipette Sales Market Share by Type (2019-2030)
4.2 Global Sterile Serological Pipette Revenue by Type (2019-2030)
4.2.1 Global Sterile Serological Pipette Revenue by Type (2019-2024)
4.2.2 Global Sterile Serological Pipette Revenue by Type (2025-2030)
4.2.3 Global Sterile Serological Pipette Revenue Market Share by Type (2019-2030)
4.3 Global Sterile Serological Pipette Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sterile Serological Pipette Sales by Application (2019-2030)
5.1.1 Global Sterile Serological Pipette Sales by Application (2019-2024)
5.1.2 Global Sterile Serological Pipette Sales by Application (2025-2030)
5.1.3 Global Sterile Serological Pipette Sales Market Share by Application (2019-2030)
5.2 Global Sterile Serological Pipette Revenue by Application (2019-2030)
5.2.1 Global Sterile Serological Pipette Revenue by Application (2019-2024)
5.2.2 Global Sterile Serological Pipette Revenue by Application (2025-2030)
5.2.3 Global Sterile Serological Pipette Revenue Market Share by Application (2019-2030)
5.3 Global Sterile Serological Pipette Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Scilogex
6.1.1 Scilogex Corporation Information
6.1.2 Scilogex Description and Business Overview
6.1.3 Scilogex Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Scilogex Sterile Serological Pipette Product Portfolio
6.1.5 Scilogex Recent Developments/Updates
6.2 Eppendorf
6.2.1 Eppendorf Corporation Information
6.2.2 Eppendorf Description and Business Overview
6.2.3 Eppendorf Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eppendorf Sterile Serological Pipette Product Portfolio
6.2.5 Eppendorf Recent Developments/Updates
6.3 Starlab
6.3.1 Starlab Corporation Information
6.3.2 Starlab Description and Business Overview
6.3.3 Starlab Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Starlab Sterile Serological Pipette Product Portfolio
6.3.5 Starlab Recent Developments/Updates
6.4 VWR International
6.4.1 VWR International Corporation Information
6.4.2 VWR International Description and Business Overview
6.4.3 VWR International Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.4.4 VWR International Sterile Serological Pipette Product Portfolio
6.4.5 VWR International Recent Developments/Updates
6.5 CELLTREAT Scientific Products
6.5.1 CELLTREAT Scientific Products Corporation Information
6.5.2 CELLTREAT Scientific Products Description and Business Overview
6.5.3 CELLTREAT Scientific Products Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CELLTREAT Scientific Products Sterile Serological Pipette Product Portfolio
6.5.5 CELLTREAT Scientific Products Recent Developments/Updates
6.6 USA Scientific
6.6.1 USA Scientific Corporation Information
6.6.2 USA Scientific Description and Business Overview
6.6.3 USA Scientific Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.6.4 USA Scientific Sterile Serological Pipette Product Portfolio
6.6.5 USA Scientific Recent Developments/Updates
6.7 CAPP
6.6.1 CAPP Corporation Information
6.6.2 CAPP Description and Business Overview
6.6.3 CAPP Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CAPP Sterile Serological Pipette Product Portfolio
6.7.5 CAPP Recent Developments/Updates
6.8 Globe Scientific
6.8.1 Globe Scientific Corporation Information
6.8.2 Globe Scientific Description and Business Overview
6.8.3 Globe Scientific Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Globe Scientific Sterile Serological Pipette Product Portfolio
6.8.5 Globe Scientific Recent Developments/Updates
6.9 Abdos Labtech
6.9.1 Abdos Labtech Corporation Information
6.9.2 Abdos Labtech Description and Business Overview
6.9.3 Abdos Labtech Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abdos Labtech Sterile Serological Pipette Product Portfolio
6.9.5 Abdos Labtech Recent Developments/Updates
6.10 SPL Life Sciences
6.10.1 SPL Life Sciences Corporation Information
6.10.2 SPL Life Sciences Description and Business Overview
6.10.3 SPL Life Sciences Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SPL Life Sciences Sterile Serological Pipette Product Portfolio
6.10.5 SPL Life Sciences Recent Developments/Updates
6.11 MIDSCI
6.11.1 MIDSCI Corporation Information
6.11.2 MIDSCI Sterile Serological Pipette Description and Business Overview
6.11.3 MIDSCI Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MIDSCI Sterile Serological Pipette Product Portfolio
6.11.5 MIDSCI Recent Developments/Updates
6.12 Thermo Fisher Scientific
6.12.1 Thermo Fisher Scientific Corporation Information
6.12.2 Thermo Fisher Scientific Sterile Serological Pipette Description and Business Overview
6.12.3 Thermo Fisher Scientific Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Thermo Fisher Scientific Sterile Serological Pipette Product Portfolio
6.12.5 Thermo Fisher Scientific Recent Developments/Updates
6.13 Tarsons
6.13.1 Tarsons Corporation Information
6.13.2 Tarsons Sterile Serological Pipette Description and Business Overview
6.13.3 Tarsons Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Tarsons Sterile Serological Pipette Product Portfolio
6.13.5 Tarsons Recent Developments/Updates
6.14 Medline Industries
6.14.1 Medline Industries Corporation Information
6.14.2 Medline Industries Sterile Serological Pipette Description and Business Overview
6.14.3 Medline Industries Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Medline Industries Sterile Serological Pipette Product Portfolio
6.14.5 Medline Industries Recent Developments/Updates
6.15 Corning
6.15.1 Corning Corporation Information
6.15.2 Corning Sterile Serological Pipette Description and Business Overview
6.15.3 Corning Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Corning Sterile Serological Pipette Product Portfolio
6.15.5 Corning Recent Developments/Updates
6.16 Greiner Bio-One
6.16.1 Greiner Bio-One Corporation Information
6.16.2 Greiner Bio-One Sterile Serological Pipette Description and Business Overview
6.16.3 Greiner Bio-One Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Greiner Bio-One Sterile Serological Pipette Product Portfolio
6.16.5 Greiner Bio-One Recent Developments/Updates
6.17 Gilson
6.17.1 Gilson Corporation Information
6.17.2 Gilson Sterile Serological Pipette Description and Business Overview
6.17.3 Gilson Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Gilson Sterile Serological Pipette Product Portfolio
6.17.5 Gilson Recent Developments/Updates
6.18 Sartorius
6.18.1 Sartorius Corporation Information
6.18.2 Sartorius Sterile Serological Pipette Description and Business Overview
6.18.3 Sartorius Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Sartorius Sterile Serological Pipette Product Portfolio
6.18.5 Sartorius Recent Developments/Updates
6.19 Bio-Rad Laboratories
6.19.1 Bio-Rad Laboratories Corporation Information
6.19.2 Bio-Rad Laboratories Sterile Serological Pipette Description and Business Overview
6.19.3 Bio-Rad Laboratories Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bio-Rad Laboratories Sterile Serological Pipette Product Portfolio
6.19.5 Bio-Rad Laboratories Recent Developments/Updates
6.20 Nest Scientific
6.20.1 Nest Scientific Corporation Information
6.20.2 Nest Scientific Sterile Serological Pipette Description and Business Overview
6.20.3 Nest Scientific Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Nest Scientific Sterile Serological Pipette Product Portfolio
6.20.5 Nest Scientific Recent Developments/Updates
6.21 Biologix
6.21.1 Biologix Corporation Information
6.21.2 Biologix Sterile Serological Pipette Description and Business Overview
6.21.3 Biologix Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Biologix Sterile Serological Pipette Product Portfolio
6.21.5 Biologix Recent Developments/Updates
6.22 TPP
6.22.1 TPP Corporation Information
6.22.2 TPP Sterile Serological Pipette Description and Business Overview
6.22.3 TPP Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.22.4 TPP Sterile Serological Pipette Product Portfolio
6.22.5 TPP Recent Developments/Updates
6.23 Sarstedt
6.23.1 Sarstedt Corporation Information
6.23.2 Sarstedt Sterile Serological Pipette Description and Business Overview
6.23.3 Sarstedt Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Sarstedt Sterile Serological Pipette Product Portfolio
6.23.5 Sarstedt Recent Developments/Updates
6.24 Merck
6.24.1 Merck Corporation Information
6.24.2 Merck Sterile Serological Pipette Description and Business Overview
6.24.3 Merck Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Merck Sterile Serological Pipette Product Portfolio
6.24.5 Merck Recent Developments/Updates
6.25 Argos Technologies
6.25.1 Argos Technologies Corporation Information
6.25.2 Argos Technologies Sterile Serological Pipette Description and Business Overview
6.25.3 Argos Technologies Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Argos Technologies Sterile Serological Pipette Product Portfolio
6.25.5 Argos Technologies Recent Developments/Updates
6.26 HiMedia
6.26.1 HiMedia Corporation Information
6.26.2 HiMedia Sterile Serological Pipette Description and Business Overview
6.26.3 HiMedia Sterile Serological Pipette Sales, Revenue and Gross Margin (2019-2024)
6.26.4 HiMedia Sterile Serological Pipette Product Portfolio
6.26.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sterile Serological Pipette Industry Chain Analysis
7.2 Sterile Serological Pipette Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sterile Serological Pipette Production Mode & Process
7.4 Sterile Serological Pipette Sales and Marketing
7.4.1 Sterile Serological Pipette Sales Channels
7.4.2 Sterile Serological Pipette Distributors
7.5 Sterile Serological Pipette Customers
8 Sterile Serological Pipette Market Dynamics
8.1 Sterile Serological Pipette Industry Trends
8.2 Sterile Serological Pipette Market Drivers
8.3 Sterile Serological Pipette Market Challenges
8.4 Sterile Serological Pipette Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Sterile Serological Pipette was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 380 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 168
USD 3950.00
(Single User License)
The global Sterile Serological Pipette market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 380 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 157
USD 2900.00
(Single User License)
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 128
USD 4250.00
(Single User License)
The global Sterile Serological Pipette market is projected to grow from US$ 256 million in 2024 to US$ 363 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 213
USD 4900.00
(Single User License)
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 187
USD 3950.00
(Single User License)
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-13
Pages: 120
USD 2900.00
(Single User License)
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published Date: 2024-04-26
Pages: 126
USD 4900.00
(Single User License)
The global market for Sterile Serological Pipette was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 380 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 168
The global Sterile Serological Pipette market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 380 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-04-17
Pages: 157
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 128
The global Sterile Serological Pipette market is projected to grow from US$ 256 million in 2024 to US$ 363 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 213
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 187
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-13
Pages: 120
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published: 2024-04-26
Pages: 126
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now